Stevanato Group S.p.A. logo

Stevanato Group S.p.A. (87N)

Market Closed
17 Jul, 20:00
XFRA XFRA
16. 70
-0.7
-4.023%
- Market Cap
45.31 P/E Ratio
0.06% Div Yield
170 Volume
0.67 Eps
17.4
Previous Close
Add Transaction
Day Range
16.7 17.7
Year Range
11.3 23.6
Want to track 87N and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

87N closed yesterday lower at €16.7, a decrease of -4.023% from Thursday's close, completing a monthly increase of 7.0513% or €1.1. Over the past 12 months, 87N stock lost -1.1834%.
87N pays dividends to its shareholders, with the most recent payment made on Jul 17, 2025. The next announced payment will be in In 1 weeks on Jul 29, 2026 for a total of €0.0622.
The last earnings report, released on May 07, 2026, missed the consensus estimates by -0.12%. On average, the company has fell short of earnings expectations by -0.1567%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NYSE (USD).

87N Chart

Stevanato: HVS Momentum Overshadows Engineering Weakness, Offering Compelling Upside

Stevanato: HVS Momentum Overshadows Engineering Weakness, Offering Compelling Upside

Stevanato Group is reiterated as a Buy, driven by robust Q1 results and a compelling long-term growth trajectory. The High-Value Solutions segment accelerated, now comprising 47% of sales, fueled by broad biologics and injectable therapies demand. Management attributed the slowdown in the Engineering segment to project timing and order delays rather than competitive pressure or deteriorating demand. Importantly, segment profitability improved despite lower volumes.

Seekingalpha | 1 month ago
Stevanato Group S.p.A. (STVN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Stevanato Group S.p.A. (STVN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Stevanato Group S.p.A. (STVN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seekingalpha | 2 months ago
Stevanato Group S.p.A. (STVN) Q1 2026 Earnings Call Transcript

Stevanato Group S.p.A. (STVN) Q1 2026 Earnings Call Transcript

Stevanato Group S.p.A. (STVN) Q1 2026 Earnings Call Transcript

Seekingalpha | 2 months ago

Stevanato Group S.p.A. (87N) FAQ

What is the stock price today?

The current price is €16.70.

On which exchange is it traded?

Stevanato Group S.p.A. is listed on XFRA.

What is its stock symbol?

The ticker symbol is 87N.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.06%.

What is its market cap?

As of today, no market cap data is available.

Has Stevanato Group S.p.A. ever had a stock split?

No, there has never been a stock split.

Stevanato Group S.p.A. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Franco Stevanato CEO
XFRA Exchange
IT0005452658 ISIN
IT Country
6,010 Employees
11 Jun 2026 Last Dividend
- Last Split
16 Jul 2021 IPO Date

Overview

Stevanato Group S.p.A. is an influential entity specializing in the design, production, and distribution of a broad range of products and services tailored for the bio-pharma and healthcare industries. Established in 1949 and operating out of Piombino Dese, Italy, the company plays a pivotal role across various global markets including Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. Stevanato Group operates through two main business segments: Biopharmaceutical and Diagnostic Solutions; and Engineering. It stands as a key subsidiary of Stevanato Holding S.R.L., demonstrating a longstanding commitment to innovation and quality in the healthcare sector.

Products and Services

  • Containment Solutions: These are designed to safely enclose pharmaceutical products, ensuring their integrity and protecting them from contamination.
  • Drug Delivery Systems: Innovative systems that facilitate the administration of pharmaceuticals to patients, enhancing the effectiveness and user experience of medication therapies.
  • Medical Devices: High-quality devices tailored for healthcare applications, contributing to diagnostics, treatment, and patient care.
  • Diagnostic and Analytical Services: Services that support the healthcare industry by providing critical insights through diagnostics and advanced analytical technologies.
  • Visual Inspection Machines: Sophisticated equipment designed for the inspection of pharmaceutical products, ensuring quality control and compliance with industry standards.
  • Assembling and Packaging Machines: Machinery engineered for the efficient assembly and packaging of pharmaceuticals, ensuring product safety and streamlined manufacturing processes.
  • Glass Forming Machines: Specialized equipment used in the manufacture of glass containers for pharmaceutical use, epitomizing precision and reliability.

Contact Information

Address: Via Molinella, 17
Phone: 39 04 99 31 811